Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-43.01%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals is performing very badly with a performance of -43.01%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -1.731% | -1.731% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-9.74%
26.04.24
26.04.24